StockData
Johnson & Johnson logo

Johnson & Johnson (JNJ) operating KPIs

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$273.20−2.00 (-0.73%)

Close on Oct 30, 2026Market cap $658.38BP/E 31.7Yield 1.88%

Johnson & Johnson medTech Segment Total — International sales ($M) ($M)

Form 10-Q / 10-K Segment Note & Form 8-K EX-99.2 Segment Sales Schedule

QuarterlyAnnual
Latest, FY2025
16,384
Period ended Dec 28, 2025
Change on a year earlier
+5.5%
15,525 in FY2024
History
11 years
Since FY2015
Sources
8
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedMedTech Segment Total — International sales ($M) ($M)Year on yearSource
FY2025Dec 28, 202516,384+5.5%Form 10-K (filed 2026-02-11) ↗
FY2024Dec 29, 202415,525+2.6%Form 10-K (filed 2026-02-11) ↗
FY2023Dec 31, 202315,125+7.7%Form 10-K (filed 2026-02-11) ↗
FY2022Jan 1, 202314,050-2.3%Form 10-K (filed 2025-02-13) ↗
FY2021Jan 2, 202214,374+20.6%Form 10-K (filed 2024-02-16) ↗
FY2020Jan 3, 202111,923-12.2%Form 10-K (filed 2023-02-16) ↗
FY2019Dec 29, 201913,579-4.1%Form 10-K (filed 2022-02-17) ↗
FY2018Dec 30, 201814,157+2.8%Form 10-K (filed 2021-02-22) ↗
FY2017Dec 31, 201713,768+7.1%Form 10-K (filed 2019-02-20) ↗
FY2016Jan 1, 201712,853-1.2%Form 10-K (filed 2019-02-20) ↗
FY2015Jan 3, 201613,005–Form 10-K (filed 2018-02-21) ↗

Breakdown

What makes up medtech segment total — international sales ($m)

Cite this data

StockData. (2026). Johnson & Johnson MedTech Segment Total — International sales ($M) ($M), annual FY2015–FY2025 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/seg_medtech_intl

See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.